FH - Familial Hypercholesterolemia

Homozygous FH
FH Global Summit 2014a

Two FDA-approved drugs for FH are extremely unaffordable. Juxtapid costs $350,000 a year. Kynamro costs $175,000 a year.

FH Global Summit 2014b
Capture - HeFH-RyLa
Capture - HeFH-KaSt

While homozygous hypercholesterolemia is rare, heterozygous type is not. The incidence is about 1:200 to 1:500. The above is an example of one such patient.

This slide below is not familial hypercholesterolemia but severe familial hypertriglyceredemia.

Familial Hypertriglyceridemia

The above is an example of someone with extremely high triglycerides. 

New Jersey Preventive Cardiology & Cholesterol Clinic, PC    © 2005           To learn more, visit us at www.CholesterolClinic.com .              Disclaimer